Suggestions appear as you type. Use the up and down arrows to choose one and Enter to open it.

This page's audience real numbers from our own analytics — open to see them
–Visitors
–Page views
–Clicks to vendors
–Time on page
–Reading now
Clicks to vendors, by tool
  • –
Top countries
  • –
Devices
  • –

– · counted by iTechGuides's own first-party analytics, bots removed, every figure rounded down · how we count

Head-to-head · Enterprise Mobility Management Software

Ivanti Neurons for MDM vs Mosyle Business

  • Updated Sep 2026
  • Both researched from official sources
  • 4 checks side by side
Higher score Ivanti Neurons for MDM #3 in Enterprise Mobility Management Software 7.7/10 Pricing on request ✓ 0 of 3 features Visit Ivanti
Mosyle Business #7 in Enterprise Mobility Management Software 7.0/10 Free plan · paid from $1/mo (annual) Free plan✓ 3 of 3 features Visit Mosyle

Ivanti Neurons for MDM leads on 0 checks, Mosyle Business on 4, and 0 are even. Who comes out ahead on the 4 yes/no, price and count checks where we have data for both products. The editor score weighs everything else too.

Our verdict

  • Highest scoreIvanti Neurons for MDM · 7.7/10
  • Free planonly Mosyle Business
  • Most featuresMosyle Business · 3 of 3

Ivanti Neurons for MDM scores higher on our rubric for enterprise mobility management software: 7.7 against 7.0 out of 10; our editors rank them #3 and #7.

Mosyle Business offers free plan; Ivanti Neurons for MDM doesn't publish it. Mosyle Business offers automated enrollment; Ivanti Neurons for MDM doesn't publish it. Mosyle Business offers app management; Ivanti Neurons for MDM doesn't publish it. Mosyle Business offers compliance policies; Ivanti Neurons for MDM doesn't publish it.

Ivanti Neurons for MDM is the better fit for enterprises needing conditional access and MAM. Mosyle Business is the better fit for small teams managing Apple devices affordably.

  • Ivanti Neurons for MDM fits best

    Enterprises needing conditional access and MAM

  • Mosyle Business fits best

    Small teams managing Apple devices affordably

Advertiser disclosure: iTechGuides is reader-supported. We may earn a commission when you click some links. How we rank.

Side by side

Feature Ivanti Neurons for MDM 7.7/10 Visit ↗ Mosyle Business 7.0/10 Visit ↗
At a glance
Editor score 7.7 7.0
Ranking #3 in Enterprise Mobility Management Software #7 in Enterprise Mobility Management Software
Best for Enterprises needing conditional access and MAM Small teams managing Apple devices affordably
Pricing model Paid Free plan + paid
Starting price Not published Not published
Free plan Not published ✓ (best)
Free trial — —
Deployment Cloud, Self-hosted Cloud, Mobile
Platforms Web Web, macOS, iOS, Android
Support Docs Tickets, Phone
Compliance SOC 2 GDPR, SOC 2
Integrations 9 integrations 6 integrations
Built for Mid-market, Enterprise Small business, Mid-market, Enterprise
Features Ivanti Neurons for MDM 0/3 · Mosyle Business 3/3
Automated enrollment Not published ✓ (best)
App management Not published ✓ (best)
Compliance policies Not published ✓ (best)
Specs
Supported platforms iOS, iPadOS, watchOS, Android, macOS, ChromeOS, Windows macOS, iOS, iPadOS, tvOS, watchOS, visionOS
Remote device actions Not published Remote configuration and management commands; remotely remove company data from BYOD devices
Deployment options Not published Cloud
Our review
Pros
  • Conditional access uses device, user, app and network signals.
  • Supports MAM without requiring device management.
  • Offers cloud and self-hosted deployment across major endpoint platforms.
  • Free management for up to 30 devices
  • Zero-touch Apple enrollment and automated app workflows
  • Security policies, scripting, and BYOD data removal
Cons
  • Pricing is quote-based, so buyers must contact sales.
  • The listed support channel is documentation.
  • Its broad device and feature coverage may be more than a narrow MDM need.
  • Management scope is centered on Apple devices
  • Paid plans require a minimum of 30 licenses
  • Paid pricing is billed annually
Our verdict

Ivanti Neurons for MDM manages corporate-owned, BYOD, rugged and shared devices, with capabilities spanning policy enforcement, apps, security monitoring, remote support and device lifecycle. It is aimed at mid-market and enterprise…

Read the review →

Mosyle Business is a cloud-based mobile device management and security platform for organizations running Apple device fleets. IT teams can enroll, configure, monitor, and manage devices through zero-touch deployment, Apple Business…

Read the review →
  1. Ivanti Neurons for MDMEnterprise Mobility Management Software 7.7Pricing on request
  2. Mosyle BusinessEnterprise Mobility Management Software 7.0Free plan · paid from $1/mo (annual)

Strengths and trade-offs

  • Ivanti Neurons for MDM — where it wins

    • Conditional access uses device, user, app and network signals.
    • Supports MAM without requiring device management.
    • Offers cloud and self-hosted deployment across major endpoint platforms.

    Where it doesn't

    • Pricing is quote-based, so buyers must contact sales.
    • The listed support channel is documentation.
    • Its broad device and feature coverage may be more than a narrow MDM need.
  • Mosyle Business — where it wins

    • Free management for up to 30 devices
    • Zero-touch Apple enrollment and automated app workflows
    • Security policies, scripting, and BYOD data removal

    Where it doesn't

    • Management scope is centered on Apple devices
    • Paid plans require a minimum of 30 licenses
    • Paid pricing is billed annually
  • Ivanti Neurons for MDM7.7/10 · Pricing on request

    Broad endpoint management with conditional access, MAM and flexible deployment options.

    Visit IvantiFull verdict →
  • Mosyle Business7.0/10 · Free plan · paid from $1/mo (annual)

    Affordable Apple device management with enrollment, apps, security policies, and BYOD controls.

    Visit MosyleFull verdict →

More comparisons

Guides on enterprise mobility management software

Reviewed by iTechGuides Editors · Editorial team · Updated Sep 2026

Last updated · How we research and update